Biotech · Private company
Sol-Gel Technologies, Ltd.
Track this companyFree. Adds Sol-Gel Technologies, Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials140 recruiting or active
Pipeline programs23From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline23
- 5-FU CreamPhase 3 · Actinic Keratosis (AK)ClinicalTrials.gov · fetched Nov 12, 2026
- Efudex®Phase 3 · Actinic Keratosis (AK)ClinicalTrials.gov · fetched Nov 12, 2026
- Patidegib Topical GelPhase 3 · Gorlin SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Patidegib Topical Gel with no active patidegibPhase 3 · Gorlin SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Patidegib Topical Gel, 2%Phase 3 · Basal Cell Nevus SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Patidegib Topical Gel, VehiclePhase 3 · Basal Cell Nevus SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- S5G4T-1Phase 3 · Papulopustular RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- S5G4T-2Phase 3 · Papulopustular RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- S6G5T-3Phase 3 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- S6G5T-8Phase 3 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 3 · Actinic Keratosis (AK)ClinicalTrials.gov · fetched Nov 12, 2026
- Patidegib Topical Gel, 2%Phase 2 · Recurrent Basal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Patidegib Topical Gel, VehiclePhase 2 · Recurrent Basal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- S2G6T-1Phase 2 · Tinea PedisClinicalTrials.gov · fetched Nov 12, 2026
- S2G6T-2Phase 2 · Tinea PedisClinicalTrials.gov · fetched Nov 12, 2026
- S2G6T-3Phase 2 · Tinea PedisClinicalTrials.gov · fetched Nov 12, 2026
- S2G6T-4Phase 2 · Tinea PedisClinicalTrials.gov · fetched Nov 12, 2026
- S6G5T-1Phase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- S6G5T-5Phase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- S6G5T-6Phase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- S6G5T-7Phase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- Encapsulated Benzoyl Peroxide CreamPhase 1 · Papulopustular RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- Retin-A® 0.1% CreamPhase 1 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials14
- Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin SyndromePHASE3 · COMPLETED · started Mar 17, 2024ClinicalTrials.gov NCT06050122 · fetched Nov 12, 2026
- Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical PropertiesPHASE1 · COMPLETED · started Jun 10, 2020ClinicalTrials.gov NCT05675501 · fetched Nov 12, 2026
- Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)PHASE3 · TERMINATED · started Jun 3, 2020ClinicalTrials.gov NCT04308395 · fetched Nov 12, 2026
- A Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCCPHASE2 · TERMINATED · started Dec 20, 2019ClinicalTrials.gov NCT04155190 · fetched Nov 12, 2026
- MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3PHASE1 · COMPLETED · started Jun 27, 2019ClinicalTrials.gov NCT04059523 · fetched Nov 12, 2026
- Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)PHASE3 · COMPLETED · started Feb 19, 2019ClinicalTrials.gov NCT03703310 · fetched Nov 12, 2026
- A Study of S6G5T-3 in the Treatment of Acne VulgarisPHASE3 · COMPLETED · started Dec 21, 2018ClinicalTrials.gov NCT03761784 · fetched Nov 12, 2026
- Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) CreamPHASE3 · COMPLETED · started Dec 21, 2018ClinicalTrials.gov NCT03727074 · fetched Nov 12, 2026
- A Study of S6G5T3 in the Treatment of Acne VulgarisPHASE3 · COMPLETED · started Dec 14, 2018ClinicalTrials.gov NCT03761810 · fetched Nov 12, 2026
- A Long-Term Safety Study of S5G4T-1 in the Treatment of Papulopustular RosaceaPHASE3 · TERMINATED · started Sep 12, 2018ClinicalTrials.gov NCT03564145 · fetched Nov 12, 2026
- A Study of S5G4T-1 in the Treatment of Papularpustular RosaceaPHASE3 · COMPLETED · started Jun 21, 2018ClinicalTrials.gov NCT03564119 · fetched Nov 12, 2026
- A Study of S5G4T-1 in the Treatment of Papulopustular RosaceaPHASE3 · COMPLETED · started Jun 18, 2018ClinicalTrials.gov NCT03448939 · fetched Nov 12, 2026
- Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea PedisPHASE2 · TERMINATED · started Sep 1, 2016ClinicalTrials.gov NCT02842021 · fetched Nov 12, 2026
- Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne VulgarisPHASE2 · COMPLETED · started May 1, 2016ClinicalTrials.gov NCT02661958 · fetched Nov 12, 2026